Foghorn Therapeutics Inc.
FHTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $89 | $73 | $61 | $55 |
| Short-Term Investments | $91 | $126 | $160 | $188 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $5 | $5 | $6 |
| Total Curr. Assets | $184 | $204 | $225 | $250 |
| Property Plant & Equip (Net) | $19 | $20 | $32 | $33 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $2 | $2 | $176 |
| Total NC Assets | $21 | $22 | $33 | $209 |
| Other Assets | $0 | $0 | $0 | -$174 |
| Total Assets | $205 | $226 | $259 | $284 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $4 | $4 |
| Short-Term Debt | $7 | $6 | $9 | $9 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $60 | $52 | $46 |
| Other Curr. Liab. | $75 | $9 | $6 | $9 |
| Total Curr. Liab. | $85 | $78 | $71 | $67 |
| LT Debt | $16 | $18 | $26 | $28 |
| Deferred Rev, NC | $0 | $207 | $222 | $234 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $194 | $1 | $1 | $0 |
| Total NC Liab. | $210 | $225 | $249 | $263 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $23 | $24 | $35 | $37 |
| Total Liabilities | $295 | $303 | $320 | $330 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$611 | -$595 | -$577 | -$558 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $521 | $518 | $515 | $513 |
| Total Equity | -$90 | -$77 | -$62 | -$46 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $205 | $226 | $259 | $284 |
| Net Debt | -$67 | -$49 | -$26 | -$18 |